Skip to main content
. Author manuscript; available in PMC: 2023 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Aug 15;90(5):546–552. doi: 10.1097/QAI.0000000000003001

Table 3:

Post vs pre-intervention attitudes towards prescribing buprenorphine among HIV clinicians (0 – 100 scale)

Baseline

Mean +/− SD		 6 month follow-up

Mean +/− SD		 12 month follow-up

Mean +/− SD		 Mean Change

(95% CI)		 p value
Interest 65.0 (34.1) 65.8 (34.3) 65.8 (34.5) −2.52 (−12.73, 7.70) 0.63
Confidence 43.6 (36.1) 54.7 (34.7) 57.6 (34.2) 12.27 (0.69, 23.84) 0.04
Readiness 44.5 (36.9) 55.4 (36.1) 57.3 (37.4) 10.89 (−0.31, 22.09) 0.06
Commitment 59.9 (35.5) 63.4 (34.6) 62.6 (36.1) 1.31 (−9.90, 12.52) 0.82

Clinicians’ attitudes of interest, confidence, readiness, and commitment to prescribe buprenorphine were measured using 0–100 visual analog scale change readiness rulers (0: Not at all – 100: Extremely). Pre-post intervention mean change in measure is shown via model results.

Abbreviations: Confidence Interval- CI, Standard deviation- SD